Atom Investors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,999
| Closed | -$357K | – | 637 |
|
|
2023
Q4 | $357K | Sell |
4,999
-171
| -3% | -$12.2K | 0.06% | 332 |
|
|
2023
Q3 | $310K | Sell |
5,170
-99
| -2% | -$5.93K | 0.07% | 318 |
|
|
2023
Q2 | $380K | Sell |
5,269
-3,266
| -38% | -$235K | 0.14% | 149 |
|
|
2023
Q1 | $628K | Buy |
8,535
+3,738
| +78% | +$275K | 0.34% | 78 |
|
|
2022
Q4 | $320K | Sell |
4,797
-11,954
| -71% | -$799K | 0.16% | 132 |
|
|
2022
Q3 | $900K | Hold |
16,751
| – | – | 0.32% | 104 |
|
|
2022
Q2 | $932K | Hold |
16,751
| – | – | 0.41% | 75 |
|
|
2022
Q1 | $1.18M | Sell |
16,751
-37
| -0.2% | -$2.6K | 0.55% | 38 |
|
|
2021
Q4 | $1.62M | Sell |
16,788
-1,967
| -10% | -$190K | 0.27% | 56 |
|
|
2021
Q3 | $1.63M | Sell |
18,755
-3,188
| -15% | -$277K | 0.13% | 72 |
|
|
2021
Q2 | $1.8M | Sell |
21,943
-4,237
| -16% | -$347K | 0.23% | 69 |
|
|
2021
Q1 | $2.49M | Sell |
26,180
-99,620
| -79% | -$9.47M | 0.42% | 47 |
|
|
2020
Q4 | $7.81M | Buy |
125,800
+59,300
| +89% | +$3.68M | 0.79% | 34 |
|
|
2020
Q3 | $3.95M | Buy |
66,500
+31,986
| +93% | +$1.9M | 0.38% | 62 |
|
|
2020
Q2 | $2.41M | Buy |
+34,514
| New | +$2.41M | 0.16% | 108 |
|